271. Ankylosing spondylitis Clinical trials / Disease details


Clinical trials : 563 Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04795141
(ClinicalTrials.gov)
August 24, 20213/3/2021ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisAnkylosing SpondylitisDrug: ABY-035;Drug: Normal salineInmagene BiopharmaceuticalsAffibodyRecruiting18 YearsN/AAll300Phase 2Cayman Islands